StonvexLoading…
StonvexStonvexStonvexCore line items from KSS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 (Est.) Expected 2026-05-27 | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|---|
Revenue | $3.02B | $15.53B | $10.35B | $6.78B | $3.23B |
Operating Income | Not available | $624.00M | $412.00M | $339.00M | $60.00M |
Net Income | Not available | $272.00M | $147.00M | $139.00M | $-15.00M |
EPS (Diluted) | $-0.19 | $2.38 | $1.30 | $1.23 | $-0.13 |
Total Assets | Not available | $13.36B | $14.14B | $13.39B | $13.64B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $674.00M | $144.00M | $174.00M | $153.00M |
Free Cash Flow OCF − CapEx | Not available | $1.01B | $322.00M | $306.00M | $-202.00M |
Shares Outstanding | Not available | 114.00M | 114.00M | 113.00M | 111.00M |